Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. II. Diet

American Journal of Epidemiology

Volumn 151, Issue 2, 2000, Pages 164-173

  Nelson, Lorene M ^a   Matkin, Chantal ^b   Longstreth, W T ^b   McGuire, Valerie ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Amyotrophic lateral sclerosis; Case control studies; Diet; Dietary fats; Dietary fiber; Epidemiologic factors; Risk factors

Indexed keywords

ANTIOXIDANT; GLUTAMIC ACID;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DIET; FAT INTAKE; FEMALE; HIGH FIBER DIET; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RISK FACTOR; UNITED STATES;

EID: 0034650162     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010184     Document Type: Article

References (60)

1. Tandan R. Upper and lower motor neuron syndromes. In: Bradley WG, Daroff RB, Fenichel GM, et al, eds. Neurology in clinical practice. Boston, MA: Buttenvorth-Heinemann, 1991:1708-17.
2. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62. (Erratum published in Nature 1993;364:362).
3. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, ! riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996;39:147-57.
4. Gurney ME. Transgenic animal models of familial amyotrophic lateral sclerosis. J Neurol 1997;244(suppl 2):S 15-20.
5. Liu D. The roles of free radicals in amyotrophic lateral sclerosis. J Mol Neurosci 1996;7:159-67.
6. Armon C, Kurland LT, Daube JR, et al. Epidemiologie correlates of sporadic amyotrophic lateral sclerosis. Neurology 1991;41:1077-84.
7. McGuire V, Longstreth WT Jr, Nelson LM, et al. Occupational | exposures and amyotrophic lateral sclerosis. A population- i based case-control study. Am J Epidemiol 1997;145:1076-88. ;
8. Rothstein JD. Excitotoxic mechanisms in the pathogenesis of ! amyotrophic lateral sclerosis. In: Serratrice GT, Munsat TL, eds. Advances in neurology. Philadelphia, PA: Lippincott- : Raven Publishers, 1995:7-20.
9. Leigh PN, Meldrum BS. Excitotoxicity in ALS. Neurology 1996;47:S221-7. :
10. Eisen A, Krieger C. Pathogenic mechanisms in sporadic amyotrophic lateral sclerosis. Can J Neurol Sei 1993;20:286-96. i
11. Roelofs-Iverson RA, Mulder DW, Elveback LR, et al. ALS and j heavy metals: a pilot case-control study. Neurology 1984;34: i 393-5.
12. Felmus MT, Patten BM, Swanke L. Antecedent events in amyotrophic lateral sclerosis. Neurology 1976;26:167-72.
13. Savettieri G, Salemi G, Arcara A, et al. A case-control study of amyotrophic lateral sclerosis. Neuroepidemiology 1991;10: 242-5.
14. Gunnarsson LG, Bodin L, Soderfeldt B, et al. A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med 1992;49:791-8.
15. Siddique T, Figlewicz DA, Pericak-Vance MA, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to
16. chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 1991;324:1381-4. (Errrata published in N Engl J Med 1991;325:71 and N Engl J Med 1991;325:524). 16 Siddique T, Hentati A. Familial amyotrophic lateral sclerosis. Clin Neurosci 1995;3:338-47.
17. Jackson M, Al-Chalabi A, Enayat ZE, et al. Copper/zinc superoxide dismutase l and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann Neural 1997;42:803-7.
18. Ferrante RJ, Browne SE, Shinobu LA, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997;69:2064-74.
19. Rothstein JD, Tsai G, Kuncl RW, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neural 1990;28:18-25.
20. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992;326:1464-8.
21. Longstreth WTJr, McGuire V, Koepsell TD, et al. Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Arch Neurol 1998;55:201-6.
22. Nelson LM, McGuire V, Longstreth WT Jr, et al. Populationbased case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol 2000; 151:156-63.
23. McGuire V, Longstreth WT Jr, Koepsell TD, et al. Incidence of amyotrophic lateral sclerosis in three counties in western Washington State. Neurology 1996;47:571-3.
24. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-69.
25. SAS Institute, Inc. SAS/STAT user's guide, version 6. Gary, NC: SAS Institute, Inc, 1990.
26. Statistics and Epidemiology Research Corporation. EGRET reference manual. Seattle, WA: Statistics and Epidemiology Research Corporation, 1991.
27. Breslow NE, Day NE, eds. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980. (IARC scientific publication no. 32).
28. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1976;35:l-39.
29. Walker AM, Velema JP, Robins JM. Analysis of case-control data derived in part from proxy respondents. Am J Epidemiol 1988;127:905-14.
30. Nelson LM, Longstreth WT Jr, Koepsell TD, et al. Proxy respondents in epidemiologic research. Epidemiol Rev 1990;12:71-86.
31. Nutrient Coordinating Center. Nutrient data system, release 2.4. Minneapolis, MN: University of Minnesota, 1992.
32. Kristal AR, Shattuck AL, Williams A. Food frequency questionnaires for diet intervention research. Proceedings of the 17th National Nutrient Databank Conference, Baltimore, MD. Washington, DC: International Life Sciences Institute, 1994: 110-25.
33. Tietz SP. Incorporation of amino acid values and animal and vegetable protein source values into the nutrient database at the Nutrient Coordinating Center. Minneapolis, MN: University of Minnesota, 1990.
34. Sienko DG, Davis JP, Taylor JA, et al. Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community. Arch Neurol 1990;47:38.
35. Logroscino G, Marder K, Cote L, et al. Dietary lipids and antioxidants in Parkinson's disease: a population-based, casecontrol study. Ann Neurol 1996;39:89-94.
36. Franklin GM, Anderson C, Checkoway-H, et al. An incident case-control study of dietary factors in Parkinson's disease. (Abstract). Neurology 1998;50:A374.
37. Penzes L, Fischer HD, Noble RC. Some aspects on the relationship between lipids, neurotransmitters, and aging. Z Gerontol 1993;26:65-9.
38. Bourre JM, Bonneil M, Clement M, et al. Function of dietary polyunsaturated fatty acids in the nervous system. Prostaglandins Leukot Essent Fatty Acids 1993;48:5-15.
39. Hall ED, Andrus PK, Oostveen JA, et al. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res 1998;53:66-77.
40. Hillemeier C. An overview of the effects of dietary fiber on gastrointestinal transit. Pediatrics 1995;96:997-9.
41. Lupton JR, Turner ND. Potential protective mechanisms of wheat bran fiber. Am J Med 1999;106:24S-7S.
42. Marsman KE, McBurney MI. Influence of dietary fiber consumption on oxidative metabolism and anaplerotic flux in isolated rat colonocytes. Comp Biochem Physiol A Physiol 1996; 115:81-9.
43. Marsman KE, McBumey MI. Dietary fiber increases oxidative metabolism in colonocytes but not in distal small intestinal enterocytes isolated from rats. J Nutr 1995;125:273-82.
44. Munakata A, Iwane S, Todate M, et al. Effects of dietary fiber on gastrointestinal transit time, fecal properties and fat absorption in rats. Tohoku J Exp Med 1995;176:227-38.
45. Spencer PS, Ludolph A, Dwivedi MP, et al. Lathryism: evidence for role of the neuroexcitatory amino acid BOAA. Lancet 1986;l:1066-7.
46. Ludolph AC, He F, Spencer PS, et al. 3-Nitropropionic acidexogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sei 1991; 18:492-8.
47. Béai MF, Brouillet E, Jenkins BG, et al. Neurochemical and histologie characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993;13:4181-92.
48. Teitelbaum JS, Zatorre RJ, Carpenter S, et al. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med 1990;322:1781-7.
49. Farrell RK, Sande RD, Lincoln SD. Nigropallidal encephalomalacia in a horse. J Am Vet Med Assoc 1971;158:1201-4.
50. Fall PA, Fredrikson M, Axelson O, et al. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 1999; 14:28-37.
51. Dagani F, D'Angelo E. Glutamate metabolism, release, and quantal transmission at central excitatory synapses: implications for neural plasticity. Funct Neurol 1992;7:315-36.
52. Toth E, Lajtha A. Elevation of cerebral levels of nonessential amino acids in vivo by administration of large doses. NeurochemRes 1981;6:1309-17.
53. Windmueller HG, Spaeth AE. Intestinal metabolism of glutamine and glutamate from the lumen as compared to glutamine from blood. Arch Biochem Biophys 1975;171:662-72.
54. Pardridge WM. Regulation of amino acid availability to brain: selective control mechanisms for glutamate. In: Filer LJ Jr, Garattini S, Kare MR, et al, eds. Glutamic acid: advances in biochemistry and physiology. New York, NY: Raven Press, 1979.
55. Babu GN, Bawari M, Ali MM. Lipid peroxidation potential and antioxidant status of circumventricular organs of rat brain following neonatal monosodium glutamate. Neurotoxicology 1994;15:773-7.
56. Plaitakis A, Caroscio JT. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 1987;22:575-9.
57. Patten BM, Harati Y, Acosta L, et al. Free amino acid levels in amyotrophic lateral sclerosis. Ann Neurol I978;3:305-9.
58. Plaitakis A, Constantakakis E, Smith J. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann Neurol 1988;24:446-9.
59. Perry TL, Hansen S, Jones K. Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology 1987;37:1845-8.
60. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994:330:585-91.